JP2023144087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023144087A5 JP2023144087A5 JP2023133147A JP2023133147A JP2023144087A5 JP 2023144087 A5 JP2023144087 A5 JP 2023144087A5 JP 2023133147 A JP2023133147 A JP 2023133147A JP 2023133147 A JP2023133147 A JP 2023133147A JP 2023144087 A5 JP2023144087 A5 JP 2023144087A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- medicament
- raav
- human subject
- glut1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562130899P | 2015-03-10 | 2015-03-10 | |
| US62/130,899 | 2015-03-10 | ||
| JP2017548205A JP2018509164A (ja) | 2015-03-10 | 2016-03-10 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
| JP2021032174A JP2021097689A (ja) | 2015-03-10 | 2021-03-01 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021032174A Division JP2021097689A (ja) | 2015-03-10 | 2021-03-01 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023144087A JP2023144087A (ja) | 2023-10-06 |
| JP2023144087A5 true JP2023144087A5 (https=) | 2024-04-08 |
Family
ID=56879055
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548205A Pending JP2018509164A (ja) | 2015-03-10 | 2016-03-10 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
| JP2021032174A Pending JP2021097689A (ja) | 2015-03-10 | 2021-03-01 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
| JP2023133147A Pending JP2023144087A (ja) | 2015-03-10 | 2023-08-17 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548205A Pending JP2018509164A (ja) | 2015-03-10 | 2016-03-10 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
| JP2021032174A Pending JP2021097689A (ja) | 2015-03-10 | 2021-03-01 | 組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20180042991A1 (https=) |
| EP (1) | EP3268024B1 (https=) |
| JP (3) | JP2018509164A (https=) |
| KR (2) | KR20240119152A (https=) |
| CN (1) | CN107635575A (https=) |
| AU (1) | AU2016229000B2 (https=) |
| CL (1) | CL2017002282A1 (https=) |
| CO (1) | CO2017010149A2 (https=) |
| DK (1) | DK3268024T3 (https=) |
| EA (1) | EA036051B1 (https=) |
| ES (1) | ES2836258T3 (https=) |
| HU (1) | HUE052577T2 (https=) |
| IL (2) | IL282053B2 (https=) |
| MX (2) | MX2017011615A (https=) |
| PT (1) | PT3268024T (https=) |
| SG (1) | SG11201707116QA (https=) |
| UA (1) | UA128249C2 (https=) |
| WO (1) | WO2016145217A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2716991C2 (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| JP6996728B2 (ja) * | 2016-01-07 | 2022-01-17 | 学校法人自治医科大学 | グルコーストランスポーター１発現用アデノ随伴ウイルスベクター |
| HUE055862T2 (hu) | 2016-04-20 | 2021-12-28 | Centro De Investig Energeticas | Készítmények és eljárások PKLR fokozott génexpressziójára |
| JOP20190200A1 (ar) | 2017-02-28 | 2019-08-27 | Univ Pennsylvania | تركيبات نافعة في معالجة ضمور العضل النخاعي |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| AU2018338728B2 (en) * | 2017-09-29 | 2025-01-02 | Centre National De La Recherche Scientifique (Cnrs) | Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery |
| US12441998B2 (en) | 2017-10-12 | 2025-10-14 | The Trustees Of Columbia University In The City Of New York | SLC2A1 lncRNA as a biologic and related treatments and methods |
| SG11202002263TA (en) | 2017-10-16 | 2020-04-29 | Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas | Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency |
| WO2019200167A1 (en) | 2018-04-11 | 2019-10-17 | Rocket Pharmaceuticals, Ltd. | Compositions and methods for stem cell transplant |
| MX2020011386A (es) | 2018-04-27 | 2021-01-29 | Spacecraft Seven Llc | Terapia genica para la degeneracion del snc. |
| AU2019265663B2 (en) * | 2018-05-08 | 2024-06-13 | Rutgers, The State University Of New Jersey | AAV-compatible laminin-linker polymerization proteins |
| KR20210019996A (ko) | 2018-05-15 | 2021-02-23 | 보이저 테라퓨틱스, 인크. | 파킨슨병의 치료를 위한 조성물 및 방법 |
| EP3856762A1 (en) | 2018-09-28 | 2021-08-04 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| US11162102B2 (en) | 2019-05-13 | 2021-11-02 | Dna Twopointo Inc. | Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products |
| AU2020346062A1 (en) * | 2019-09-13 | 2022-03-24 | Rutgers, The State University Of New Jersey | AAV-compatible laminin-linker polymerization proteins |
| US20230302104A1 (en) * | 2020-05-01 | 2023-09-28 | Atlas Biotechnology S.A. | Treatment and/or prevention of a disease or a syndrome related to a virus infection |
| CA3185234A1 (en) * | 2020-07-09 | 2022-01-13 | Dorota Danuta KLYSZ | Immune cells with increased glycolytic flux |
| CN116113700A (zh) * | 2020-08-05 | 2023-05-12 | 太空飞船七有限责任公司 | 用于glut1表达的腺相关病毒载体及其用途 |
| KR20230043869A (ko) | 2020-08-07 | 2023-03-31 | 스페이스크래프트 세븐, 엘엘씨 | Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법 |
| WO2022051627A2 (en) * | 2020-09-04 | 2022-03-10 | Dna Twopointo Inc. | Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products |
| IL314602A (en) * | 2022-02-08 | 2024-09-01 | Spacecraft Seven Llc | Adeno-associated viral vector for GLUT1 expression and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| EP0931158A1 (en) | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| MX359371B (es) | 2001-11-13 | 2018-09-25 | Univ Pennsylvania | Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo. |
| ES2740827T3 (es) * | 2003-05-02 | 2020-02-06 | Centre Nat Rech Scient | GLUT-1 como receptor de envolturas del HTLV y sus usos |
| JP2006345703A (ja) * | 2003-09-09 | 2006-12-28 | Osaka Industrial Promotion Organization | 高発現型汎用哺乳動物宿主細胞 |
| EP2345731B1 (en) | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| ES2525067T3 (es) | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| WO2008134632A1 (en) * | 2007-04-26 | 2008-11-06 | President And Fellows Of Harvard College | Wnt ligands involved in blood-brain barrier development and uses therefor |
| WO2010071832A1 (en) * | 2008-12-19 | 2010-06-24 | Nationwide Children's Hospital | Delivery of polynucleotides across the blood brain barrier using recombinant aav9 |
| US9610363B2 (en) * | 2009-04-16 | 2017-04-04 | President And Fellows Of Harvard College | Methods for inhibiting starvation of a cell |
| EP2561073B1 (en) * | 2010-04-23 | 2016-08-24 | University of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| EP2394667A1 (en) * | 2010-06-10 | 2011-12-14 | Laboratorios Del Dr. Esteve, S.A. | Vectors and sequences for the treatment of diseases |
-
2016
- 2016-03-10 KR KR1020247024535A patent/KR20240119152A/ko not_active Ceased
- 2016-03-10 DK DK16762530.0T patent/DK3268024T3/da active
- 2016-03-10 PT PT167625300T patent/PT3268024T/pt unknown
- 2016-03-10 SG SG11201707116QA patent/SG11201707116QA/en unknown
- 2016-03-10 IL IL282053A patent/IL282053B2/en unknown
- 2016-03-10 JP JP2017548205A patent/JP2018509164A/ja active Pending
- 2016-03-10 EP EP16762530.0A patent/EP3268024B1/en active Active
- 2016-03-10 US US15/556,412 patent/US20180042991A1/en not_active Abandoned
- 2016-03-10 ES ES16762530T patent/ES2836258T3/es active Active
- 2016-03-10 KR KR1020177028554A patent/KR20180016722A/ko not_active Ceased
- 2016-03-10 AU AU2016229000A patent/AU2016229000B2/en not_active Ceased
- 2016-03-10 EA EA201791936A patent/EA036051B1/ru unknown
- 2016-03-10 MX MX2017011615A patent/MX2017011615A/es unknown
- 2016-03-10 HU HUE16762530A patent/HUE052577T2/hu unknown
- 2016-03-10 CN CN201680025266.9A patent/CN107635575A/zh active Pending
- 2016-03-10 UA UAA201709758A patent/UA128249C2/uk unknown
- 2016-03-10 WO PCT/US2016/021810 patent/WO2016145217A1/en not_active Ceased
-
2017
- 2017-09-03 IL IL254286A patent/IL254286B/en active IP Right Grant
- 2017-09-08 MX MX2023001213A patent/MX2023001213A/es unknown
- 2017-09-08 CL CL2017002282A patent/CL2017002282A1/es unknown
- 2017-10-05 CO CONC2017/0010149A patent/CO2017010149A2/es unknown
-
2020
- 2020-11-19 US US16/952,801 patent/US20210069292A1/en not_active Abandoned
-
2021
- 2021-03-01 JP JP2021032174A patent/JP2021097689A/ja active Pending
-
2023
- 2023-08-17 JP JP2023133147A patent/JP2023144087A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023144087A5 (https=) | ||
| Hardcastle et al. | AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials | |
| JP2022153418A5 (https=) | ||
| CA2529179C (en) | Recombinant adeno-associated virus vector for treatment of alzheimer disease | |
| JP2023002555A5 (https=) | ||
| JP2021531752A5 (https=) | ||
| US20150374803A1 (en) | Adeno-associated virus vectors and methods of use thereof | |
| JP2021003120A (ja) | 止血疾患を治療するための変異因子ｖｉｉｉのゲノム組込及び発現のための改良された発現カセット | |
| KR20140023298A (ko) | 당뇨병, 저혈당 및 관련 장애를 치료 및 예방하기 위한 인슐린과 크롬을 포함하는 조성물 | |
| ES2968038T3 (es) | Agonista GLP-1R de acción prolongada como terapia de afecciones neurológicas y neurodegenerativas | |
| JP2022520232A5 (https=) | ||
| JP2023545731A5 (https=) | ||
| JP2021520811A (ja) | ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックａａｖベクターならびにその使用 | |
| JP2017513500A5 (https=) | ||
| JP2024517143A5 (https=) | ||
| JP2024539123A5 (https=) | ||
| JP2020527167A5 (https=) | ||
| CN117321212A (zh) | 用于治疗法布里病的组合物和方法 | |
| JP2022519597A5 (https=) | ||
| CA2934948A1 (en) | Compositions and methods for providing active telomerase to cells in vivo | |
| JP2024527742A5 (https=) | ||
| US20100256057A1 (en) | Method of preventing or treating body weight disorders by employing clusterin | |
| JP2022530359A5 (https=) | ||
| US20250017958A1 (en) | Combinatorial therapeutic approach for friedreich's ataxia | |
| JP2022530264A5 (https=) |